drugset / Trial / NCT06474299
The Avenues Study: Dual Use Cessation
Phase 4
Recruiting
500 enrolled
University of Wisconsin, Madison
National Cancer Institute (NCI) · collab
RandomizedFactorialOpen-labelTreatment
Summary
The overarching goal of this research is to determine the most effective approach for helping dual users of cigarettes and electronic nicotine delivery systems (ENDS) quit smoking. 500 participants will be enrolled and can expect to be on study for 12 months.
Timeline
- Start
- 2024-09-24
- Primary completion
- 2028-07
- Completion
- 2028-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nicotine patch | Unknown | 14 mg | — |
| Comparator | Nicotine patch | Unknown | 21 mg | — |
| Comparator | Varenicline | Small molecule | 1 mg | — |
Indications
No indication recorded.